These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 33299311)

  • 1. Erratum: Efficient Inhibition of Ovarian Cancer by Degradable Nanoparticle-Delivered Survivin
    Int J Nanomedicine; 2020; 15():9669-9670. PubMed ID: 33299311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient inhibition of ovarian cancer by degradable nanoparticle-delivered survivin T34A gene.
    Luo L; Du T; Zhang J; Zhao W; Cheng H; Yang Y; Wu Y; Wang C; Men K; Gou M
    Int J Nanomedicine; 2016; 11():501-12. PubMed ID: 26893558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-Assembled Nanoparticle Mediated
    Xiao Y; Wang C; Xiong M; Yang Y; Zhang Q; Liu X; Zou B; Gou M
    J Biomed Nanotechnol; 2018 Dec; 14(12):2092-2101. PubMed ID: 30305216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Procaspase 3 expression in ovarian carcinoma cells increases survivin transcription which can be countered with a dominant-negative mutant, survivin T34A; a combination gene therapy strategy.
    McKay TR; Bell S; Tenev T; Stoll V; Lopes R; Lemoine NR; McNeish IA
    Oncogene; 2003 Jun; 22(23):3539-47. PubMed ID: 12789262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erratum: A Smart Multifunctional Nanoparticle for Enhanced Near-Infrared Image-Guided Photothermal Therapy Against Gastric Cancer [Corrigendum].
    Int J Nanomedicine; 2021; 16():3121-3123. PubMed ID: 33976545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local and systemic delivery of mRNA encoding survivin-T34A by lipoplex for efficient colon cancer gene therapy.
    Zhang X; Men K; Zhang Y; Zhang R; Yang L; Duan X
    Int J Nanomedicine; 2019; 14():2733-2751. PubMed ID: 31118608
    [No Abstract]   [Full Text] [Related]  

  • 7. Erratum: Targeting EZH2 for glioma therapy with a novel nanoparticle-siRNA complex [Corrigendum].
    Int J Nanomedicine; 2019; 14():6587-6588. PubMed ID: 32461716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erratum: Exosome-Delivered c-Met siRNA Could Reverse Chemoresistance to Cisplatin in Gastric Cancer [Corrigendum].
    Int J Nanomedicine; 2022; 17():1003-1004. PubMed ID: 35313459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erratum: miR-221 Suppression Through Nanoparticle-Based miRNA Delivery System for Hepatocellular Carcinoma Therapy and Its Diagnosis as a Potential Biomarker [Corrigendum].
    Int J Nanomedicine; 2020; 15():8293-8294. PubMed ID: 33149576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erratum: Quercetin nanoparticle complex attenuated diabetic nephropathy via regulating the expression level of ICACAM-1 on endothelium [Corrigendum].
    Int J Nanomedicine; 2022; 17():2503-2504. PubMed ID: 35677679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erratum: A Comparison Of Poly-ethylene-glycol-Coated And Uncoated Gold Nanoparticle-Mediated Hepatotoxicity And Oxidative Stress In Sprague-Dawley Rats [Corrigendum].
    Int J Nanomedicine; 2019; 14():7793. PubMed ID: 31576123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erratum: CD-340 Functionalized Doxorubicin-Loaded Nanoparticle Induces Apoptosis And Reduces Tumor Volume Along With Drug-Related Cardiotoxicity In Mice [Corrigendum].
    Int J Nanomedicine; 2019; 14():9307. PubMed ID: 31819432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erratum: CD-340 Functionalized Doxorubicin-Loaded Nanoparticle Induces Apoptosis and Reduces Tumor Volume Along with Drug-Related Cardiotoxicity in Mice [Corrigendum].
    Int J Nanomedicine; 2021; 16():1001-1003. PubMed ID: 33603364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erratum: Design and Self-Assembly of Peptide-Copolymer Conjugates into Nanoparticle Hydrogel for Wound Healing in Diabetes [Corrigendum].
    Int J Nanomedicine; 2024; 19():4297-4298. PubMed ID: 38766659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of Survivin-T34A mutant on breast cancer cell in vitro and in vivo].
    Deng X; Song H; Ren M
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2014 Jun; 31(3):648-51. PubMed ID: 25219251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erratum: Synthesis, Construction, and Evaluation of Self-Assembled Nano-Bacitracin a as an Efficient Antibacterial Agent in vitro and in vivo [Corrigendum].
    Int J Nanomedicine; 2020; 15():4753. PubMed ID: 32753863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Preparation of recombinant HIV-TATm-survivin (T34A) protein and its pro-apoptosis activity to cancer cells in vitro].
    Zheng WY; Ma XY; Wei DZ; Wang JZ; Liu QH; Ma YS; Yang SL
    Sheng Wu Gong Cheng Xue Bao; 2006 Mar; 22(2):285-92. PubMed ID: 16607958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erratum: Synthesis of Ginsenoside Re-Based Carbon Dots Applied for Bioimaging and Effective Inhibition of Cancer Cells [Corrigendum].
    Int J Nanomedicine; 2020; 15():10149-10150. PubMed ID: 33354108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anti-prostate cancer activity of Survivin-T34A mutant in vitro and in vivo].
    Pan L; Peng XC; Yuan QZ; Leng F; Yu DD; Shan Y; Li ZY; Wang CT
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 May; 41(3):390-3. PubMed ID: 20629305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erratum: Anti-Inflammatory Effects of Magnetically Targeted Mesenchymal Stem Cells on Laser-Induced Skin Injuries in Rats [Corrigendum].
    Int J Nanomedicine; 2020; 15():6735-6736. PubMed ID: 33061356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.